应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00874 白云山
国庆日休市 09-30 16:08:27
13.310
+0.230
+1.76%
最高
13.340
最低
12.950
成交量
109.80万
今开
12.960
昨收
13.080
日振幅
2.98%
总市值
216.42亿
流通市值
29.27亿
总股本
16.26亿
成交额
1,453万
换手率
0.50%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
股市必读:白云山(600332)9月28日董秘有最新回复
证券之星 · 09-29 01:31
股市必读:白云山(600332)9月28日董秘有最新回复
白云山:该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品
证券之星 · 09-28
白云山:该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品
白云山:截至2026年6月30日股东数为110,167户
证券之星 · 09-28
白云山:截至2026年6月30日股东数为110,167户
白云山:推动基石业务板块提质增效
证券之星 · 09-28
白云山:推动基石业务板块提质增效
白云山(600332)披露控股股东股权结构变更公告,9月22日股价下跌0.25%
证券之星 · 09-22
白云山(600332)披露控股股东股权结构变更公告,9月22日股价下跌0.25%
白云山(00874)披露控股股东股权结构调整:广药集团注册资本增至14.65亿元,实际控制权不变
公告速递 · 09-21
白云山(00874)披露控股股东股权结构调整:广药集团注册资本增至14.65亿元,实际控制权不变
每周股票复盘:白云山(600332)回应分红、研发及海外布局
证券之星 · 09-20
每周股票复盘:白云山(600332)回应分红、研发及海外布局
白云山:9月14日召开业绩说明会,全体股东参与
证券之星 · 09-18
白云山:9月14日召开业绩说明会,全体股东参与
王老吉继续“降温”
蓝鲸财经 · 09-15
王老吉继续“降温”
股市必读:白云山新发布《广州白云山医药集团股份有限公司关于股权投资基金事项变更暨关联交易进展公告》
证券之星 · 09-14
股市必读:白云山新发布《广州白云山医药集团股份有限公司关于股权投资基金事项变更暨关联交易进展公告》
广药瞄准美妆赛道,白云山美妆去年商品交易总额达25亿元
南方都市报 · 09-12
广药瞄准美妆赛道,白云山美妆去年商品交易总额达25亿元
白云山新提交“王老吉东方五行”商标注册申请
证券之星 · 09-12
白云山新提交“王老吉东方五行”商标注册申请
白云山(600332)披露股权投资基金基金管理人变更暨关联交易进展公告,9月11日股价下跌0.75%
证券之星 · 09-11
白云山(600332)披露股权投资基金基金管理人变更暨关联交易进展公告,9月11日股价下跌0.75%
白云山(00874)调整广药金藏基金管理人 4,600万元出资比例维持40%
公告速递 · 09-11
白云山(00874)调整广药金藏基金管理人 4,600万元出资比例维持40%
王老吉继续“降温”
斑马消费 · 09-10
王老吉继续“降温”
白云山(00874.HK)旗下白云山生物获澳门冻干人用狂犬病疫苗《成药登记证书》
公告速递 · 09-08
白云山(00874.HK)旗下白云山生物获澳门冻干人用狂犬病疫苗《成药登记证书》
股市必读:白云山新发布《广州白云山医药集团股份有限公司2026年半年度权益分派实施公告》
证券之星 · 09-07
股市必读:白云山新发布《广州白云山医药集团股份有限公司2026年半年度权益分派实施公告》
每周股票复盘:白云山(600332)每股派息0.30元含税
证券之星 · 09-06
每周股票复盘:白云山(600332)每股派息0.30元含税
白云山(00874)拟于9月14日召开2026年半年度业绩说明会
公告速递 · 09-04
白云山(00874)拟于9月14日召开2026年半年度业绩说明会
白云山:2026年半年度权益分派实施公告
证券日报网 · 09-03
白云山:2026年半年度权益分派实施公告
加载更多
公司概况
公司名称:
白云山
所属市场:
SEHK
上市日期:
--
主营业务:
广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":13.31,"timestamp":1790755707002,"preClose":13.08,"halted":0,"volume":1098000,"delay":0,"changeRate":0.017584097859327248,"floatShares":219900000,"shares":1626000000,"eps":2.143309949780289,"marketStatus":"国庆日休市","change":0.23,"latestTime":"09-30 16:08:27","open":12.96,"high":13.34,"low":12.95,"amount":14533960,"amplitude":0.029817,"askPrice":13.33,"askSize":40000,"bidPrice":13.31,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.8410530221594479,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":13.08,"dividendRate":0.064838,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.0463885585004136,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":19.72,"timestamp":1790751600000,"preClose":19.4,"halted":0,"volume":5685400,"delay":0,"premium":"-42.21"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2671254538","title":"股市必读:白云山(600332)9月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254538?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:31","pubTimestamp":1790616671,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,白云山报收于19.45元,上涨0.31%,换手率0.32%,成交量4.55万手,成交额8838.18万元。股价持续下跌表明市场不认同公司传递的公司价值。公司披露的最新股东户数是截至2026年6月30日的户数,股东数为110,167户。该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品。当日关注点交易信息汇总:9月28日主力资金净流出530.89万元,占总成交额6.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0196","BK1191","600332","BK0070","BK1197","BK1521","BK0028","00874","BK0012","BK0188","BK0239","BK0097","BK1606","BK1515","BK0183","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670233072","title":"白云山:该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2670233072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670233072?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:42","pubTimestamp":1790588526,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)09月28日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,请问广药牌灵芝孢子油产品收入100%属于上市公司旗下吗白云山回复:尊敬的投资者您好,感谢您的关注!该产品是公司持股比例为75.11%的控股子公司白云山汉方旗下产品。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800022896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","600332","BK0175","BK1606","BK0097","BK1197","BK1521","BK0028","BK0012","BK0183","BK0070","BK0196","00874","BK0096","BK0239","BK0188","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670238029","title":"白云山:截至2026年6月30日股东数为110,167户","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238029","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670238029?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:15","pubTimestamp":1790586915,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)09月28日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,本公司到2026年8月31号股东户数是多少?白云山回复:尊敬的投资者您好,感谢您的关注!公司披露的最新股东户数是截至2026年6月30日的户数,股东数为110,167户。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800022236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","00874","BK0096","BK0239","600332","BK0070","BK0196","BK1191","BK1521","BK1606","BK0012","BK0175","BK1197","BK0188","BK0097","BK0028","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670238224","title":"白云山:推动基石业务板块提质增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238224","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670238224?lang=zh_cn&edition=full","pubTime":"2026-09-28 17:06","pubTimestamp":1790586373,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山09月28日在投资者关系平台上答复投资者关心的问题。股价持续下跌表明市场不认同公司传递的公司价值。公司将推动基石业务板块提质增效,培育新动能促发展;继续推动创新转型,聚力锻强科技引擎;进一步推进国际化进程,强化资本运作,主动释放公司价值。公司将不断加强市值管理工作,争取给投资者更好的投资回报。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800022064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0188","BK1197","BK1191","BK1515","BK1521","BK0239","BK0096","BK1606","BK0012","00874","BK0070","BK0183","600332","BK0175","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148778","title":"白云山(600332)披露控股股东股权结构变更公告,9月22日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148778","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148778?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070386,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,白云山报收于19.68元,较前一交易日下跌0.25%,最新总市值为319.96亿元。该股当日开盘19.73元,最高19.76元,最低19.6元,成交额达8815.22万元,换手率为0.32%。广州白云山医药集团股份有限公司于近日发布《关于控股股东股权结构变更的提示性公告》。本次变更后,公司控股股东及实际控制人未发生变化,不影响公司主要业务结构及正常经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0175","BK0028","600332","BK1515","BK0196","BK1521","BK1197","BK0070","00874","BK0096","BK0183","BK0239","BK1191","BK0097","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114087925","title":"白云山(00874)披露控股股东股权结构调整:广药集团注册资本增至14.65亿元,实际控制权不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1114087925","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114087925?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:37","pubTimestamp":1789983457,"startTime":"0","endTime":"0","summary":"2026年9月21日,白云山公告称,公司控股股东广州医药集团有限公司已完成股权结构工商变更手续,其注册资本由12.53亿元增至14.65亿元。公告指出,此次股权结构调整仅涉及广药集团内部的出资比例变化,不影响广药集团持有的白云山股份数量及持股比例。白云山的控股股东及实际控制人均保持不变,公司主营业务与日常经营活动不受影响。白云山董事会表示,将继续关注控股股东后续动态,并按相关规定及时履行信息披露义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906487","title":"每周股票复盘:白云山(600332)回应分红、研发及海外布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906487?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:17","pubTimestamp":1789838228,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘,白云山报收于19.52元,较上周的19.73元下跌1.06%。本周,白云山9月14日盘中最高价报19.83元。答:2025年研发费用下降主要是因为部分研发项目阶段性支出下降所致,属于阶段性波动。2026年上半年,公司研发费用同比增长20.36%。2026年上半年,王老吉海外出口额同比增长较大,主要依托重点市场WLOVI红罐及红瓶持续铺货、海外渠道趋向精细化营运,带来东南亚、欧洲渠道稳步拓展。目前,广州医药已申请超10种放射性核素。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0012","BK0196","00874","BK0183","BK0175","BK0239","BK0188","BK1191","BK1197","600332","BK1521","BK1515","BK0097","BK0028","BK0096","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668926707","title":"白云山:9月14日召开业绩说明会,全体股东参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2668926707","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668926707?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:20","pubTimestamp":1789737631,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月18日白云山发布公告称公司于2026年9月14日召开业绩说明会,全体股东参与。2026年上半年,公司研发费用同比增长20.36%。公司将持续积极推进相关工作,并根据项目进展情况严格按照相关规定及时履行披露义务。目前,广州医药已申请超10种放射性核素。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800035946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","600332","BK0175","BK1606","BK0097","BK1197","BK1521","BK0028","BK0012","BK0183","BK0070","BK0196","00874","BK0096","BK0239","BK0188","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667118556","title":"王老吉继续“降温”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667118556","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667118556?lang=zh_cn&edition=full","pubTime":"2026-09-15 14:17","pubTimestamp":1789453022,"startTime":"0","endTime":"0","summary":"2025年,王老吉大健康公司营收小幅企稳,录得收入87.86亿元,净利润回升至12.02亿元,但始终未重现此前的增长势头。王老吉大健康公司的经营波动,直接牵动天然饮品板块的整体表现。这也反映出王老吉凉茶产品在终端动销走弱,传统单一凉茶大单品的增长红利已经消退,产品销售规模进入持续收缩阶段。在代言人布局上,王老吉去年签约张凌赫、世界杯期间签约哈兰德;今年8月在签约李昀锐代言“王者英雄能量电解质饮料”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789001106238300805","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1515","BK1197","BK1521","BK1606","BK1191","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638996","title":"股市必读:白云山新发布《广州白云山医药集团股份有限公司关于股权投资基金事项变更暨关联交易进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638996?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:27","pubTimestamp":1789327630,"startTime":"0","endTime":"0","summary":"公司公告汇总广州白云山医药集团股份有限公司关于股权投资基金事项变更暨关联交易进展公告广州白云山医药集团股份有限公司发布公告,旗下广州广药金藏股权投资合伙企业拟变更基金管理人,由广东广药金申股权投资基金管理有限公司变更为广州广药资本私募基金管理有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1606","BK0070","159938","BK0175","BK0188","BK0096","BK1197","600332","BK0196","BK1161","BK0028","BK1191","00874","BK0012","BK0183","BK1515","BK0097","09939","BK1574","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666041345","title":"广药瞄准美妆赛道,白云山美妆去年商品交易总额达25亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666041345","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666041345?lang=zh_cn&edition=full","pubTime":"2026-09-12 22:07","pubTimestamp":1789222076,"startTime":"0","endTime":"0","summary":"广药集团正在瞄准美妆赛道。9月12日,由广药白云山全资子公司广州广药创赢、厦门海尼集团合资创立的广药大美丽生物科技(广州)有限公司,在穗揭牌。据悉,该公司注册地位于广州生物岛,注册资本2000万元,全面承接白云山美妆品牌自主运营业务,聚焦美妆、个护、大健康、家清四大赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609123872764111.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609123872764111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK0196","BK0239","BK0028","BK0183","BK0097","BK1197","BK1191","BK1606","00874","BK0070","BK0175","BK0188","BK1521","BK0012","BK0096","600332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666908577","title":"白云山新提交“王老吉东方五行”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666908577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666908577?lang=zh_cn&edition=full","pubTime":"2026-09-12 07:27","pubTimestamp":1789169248,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日广州白云山医药集团股份有限公司新提交“王老吉东方五行”商标注册申请。商标申请详情如下:今年以来广州白云山医药集团股份有限公司新申请注册商标27件,截止目前公司共持有注册商标4647件,另有388件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200006599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","BK0239","BK0097","BK1197","BK0012","BK0070","BK1606","BK0188","BK1521","BK1515","BK0175","BK0028","BK0196","BK1191","600332","BK0183","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666578647","title":"白云山(600332)披露股权投资基金基金管理人变更暨关联交易进展公告,9月11日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666578647","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666578647?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:29","pubTimestamp":1789136994,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,白云山报收于19.73元,较前一交易日下跌0.75%,最新总市值为320.77亿元。该股当日开盘19.83元,最高19.87元,最低19.56元,成交额达1.43亿元,换手率为0.52%。近日,广州白云山医药集团股份有限公司发布《关于股权投资基金事项变更暨关联交易进展公告》。本次变更系因原管理人拟注销私募基金管理人登记,新管理人广药私募为公司控股股东广药集团全资子公司,已在中国证券投资基金业协会登记备案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK1191","BK0070","BK0097","BK0096","BK1515","BK1521","BK0028","BK1197","BK0175","BK0196","BK1606","BK0183","BK0188","600332","00874","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106423683","title":"白云山(00874)调整广药金藏基金管理人 4,600万元出资比例维持40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106423683","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106423683?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:12","pubTimestamp":1789117968,"startTime":"0","endTime":"0","summary":"2026年9月11日,广州白云山医药集团股份有限公司公告称,其参投的广州广药金藏股权投资合伙企业拟变更基金管理人。现任管理人、普通合伙人兼执行事务合伙人广东广药金申股权投资基金管理有限公司计划注销私募基金管理人登记,基金管理人将调整为广州广药资本私募基金管理有限公司。白云山作为有限合伙人认缴出资4,600万元,占基金认缴份额的40%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666503045","title":"王老吉继续“降温”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666503045","media":"斑马消费","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666503045?lang=zh_cn&edition=full","pubTime":"2026-09-10 07:39","pubTimestamp":1788997140,"startTime":"0","endTime":"0","summary":"2025年,王老吉大健康公司营收小幅企稳,录得收入87.86亿元,净利润回升至12.02亿元,但始终未重现此前的增长势头。王老吉大健康公司的经营波动,直接牵动天然饮品板块的整体表现。这也反映出王老吉凉茶产品在终端动销走弱,传统单一凉茶大单品的增长红利已经消退,产品销售规模进入持续收缩阶段。在代言人布局上,王老吉去年签约张凌赫、世界杯期间签约哈兰德;今年8月在签约李昀锐代言“王者英雄能量电解质饮料”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0MDY2ODM2MQ==&mid=2247524861&idx=1&sn=6704ad15dcfa4e1477a2d9c1c7dd5a1a&chksm=e8caf9d130071cc39268348b256d12f49af046b38ee8a53d83cab23899727a42d54065ca5859&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1606","BK1197","BK1521","BK1515","BK1191","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172809579","title":"白云山(00874.HK)旗下白云山生物获澳门冻干人用狂犬病疫苗《成药登记证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=1172809579","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172809579?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:52","pubTimestamp":1788861136,"startTime":"0","endTime":"0","summary":"2026年9月8日,广州白云山医药集团股份有限公司公告称,其合并报表范围内企业广州白云山生物制品股份有限公司已收到澳门特别行政区政府药物监督管理局签发的冻干人用狂犬病疫苗《成药登记证书》,登记编号为MAC-08579,剂型为注射剂,药品类别为处方药,申请登记人为广药国际(澳门)药物产品出入口及批发商号,制造商为白云山生物。白云山生物于2026年5月26日向澳门药监局递交该疫苗的注册申请,并于2026年8月13日获得预先许可受理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665627263","title":"股市必读:白云山新发布《广州白云山医药集团股份有限公司2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665627263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665627263?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:15","pubTimestamp":1788714911,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,白云山报收于20.24元,上涨0.25%,换手率0.55%,成交量7.7万手,成交额1.56亿元。公司公告汇总:白云山将于2026年9月10日实施2026年半年度权益分派,每股派发现金红利0.30元(含税),共计派发487,737,284.70元(含税)。A股股东中,无限售流通股红利由中国结算上海分公司派发,部分股东由公司直接发放。涉及个人、QFII、沪股通等不同股东类型的税收处理方式。H股股东分红不适用本公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0239","BK1574","BK1521","BK1191","BK1161","BK0183","BK0070","BK0096","BK0028","BK0012","600332","09939","BK0097","159938","BK1515","00874","BK1197","BK1606","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365701","title":"每周股票复盘:白云山(600332)每股派息0.30元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365701","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365701?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:46","pubTimestamp":1788633972,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,白云山报收于20.24元,较上周的20.42元下跌0.88%。本周,白云山8月31日盘中最高价报20.43元。本周关注点公司公告汇总:白云山2026年半年度每股派发现金红利0.30元(含税),股权登记日为2026年9月9日。公司公告汇总广州白云山医药集团股份有限公司提交截至2026年8月31日的证券变动月报表。本次分配以公司总股本1,625,790,949股为基数,共派发现金红利487,737,284.70元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK1191","BK0070","BK0097","BK0096","BK1515","BK1521","BK0028","BK1197","BK0175","BK0196","BK1606","BK0183","BK0188","600332","00874","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142234673","title":"白云山(00874)拟于9月14日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1142234673","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142234673?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:15","pubTimestamp":1788516934,"startTime":"0","endTime":"0","summary":"公司已于2026年8月22日披露2026年半年度报告。本次说明会旨在帮助投资者更全面了解公司上半年经营成果与财务状况,并就投资者普遍关注的问题进行交流。投资者可在9月7日(星期一)至9月11日(星期五)16:00前,登录上证路演中心“提问预征集”栏目或通过公司邮箱sec@gybys.com.cn提交问题;公司将于说明会上集中回应。说明会结束后,投资者可通过上证路演中心查询会议回放及主要内容。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083968","title":"白云山:2026年半年度权益分派实施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083968","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664083968?lang=zh_cn&edition=full","pubTime":"2026-09-03 21:32","pubTimestamp":1788442320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月3日,白云山发布2026年半年度权益分派实施公告称,本次利润分配以方案实施前的公司总股本1,625,790,949股为基数,每股派发现金红利0.30元(含税),共计派发现金红利487,737,284.70元(含税)。股权登记日为2026年9月9日,除权(息)日为2026年9月10日。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0097","BK0070","BK1191","BK1515","BK0096","BK1606","00874","BK1197","BK0175","600332","BK0012","BK0239","BK0028","BK1521","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0008},{"period":"1month","weight":-0.0169},{"period":"3month","weight":-0.0679},{"period":"6month","weight":-0.1791},{"period":"1year","weight":-0.2241},{"period":"ytd","weight":-0.2027}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009908},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058543},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049537},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081866},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044368},{"month":6,"riseRate":0.482759,"avgChangeRate":0.018954},{"month":7,"riseRate":0.448276,"avgChangeRate":-0.011349},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.040031},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.01093},{"month":10,"riseRate":0.428571,"avgChangeRate":0.004089},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008393},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023642}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}